[Low grade fibromixoid sarcoma: a purpose of 3 cases and review of the bibliography].
[Low grade fibromixoid sarcoma: a purpose of 3 cases and review of the bibliography].
BACKGROUND
Low grade fibromyxoid sarcoma or tumor Evans is a variety of soft tissue sarcoma that represents 1% of all malignancies. More common in limbs and trunk (50%), we present 3 new cases of retroperitoneal reviewing their characteristics and performing a literature review.
METHODS
In the retroperitoneal location highlights the poor specificity of clinical symptoms, demonstrating, according to their growth and size, as an abdominal tumor, usually painless, or by compression and/or invasion of nearby structures. In cases that present the most important finding was the presence of a palpable abdominal tumor without other symptoms despite remarkable infiltration of other organs that should be included in surgical resection.
CONCLUSIONS
We emphasize the difficulty of correct diagnosis preoperatively because preoperative studies are inconclusive and only the histological and immuno–histo-typing chemistry allow precise identification.
[Determination of ER-D5 (estrogen receptor related antigen) in prostatic cancer and its significance].
The existence of an estrogen receptor and various other sex steroid receptors has been confirmed in prostatic cancer. However, the action mechanism of hormone therapy and relationship between the disappearance of hormone response, which is observed in the recurrence of prostatic cancer, and various sex steroid receptors have yet to be identified. The use of monoclonal antibody ERICA is known as a method of detecting the estrogen receptor in the immuno–histological chemistry method. However, this monoclonal antibody is difficult to use on paraffin sections. Therefore, using monoclonal antibody D5, which allows ER-D5 detection of the estrogen receptor related antigen on paraffin sections, we investigated whether or not estrogen receptors are present in the prostatic cancer preparation and studied the survival rate of prostatic cancer as well as relationship with recurrence.
Positive ER-D5 results were obtained in 37 of 93 prostatic cancer cases (39.8%) and in all 20 prostatic hypertrophy cases (100%). ER-D5 tended to be more densely stained in prostatic hypertrophy than in prostatic cancer. The survival rate was obviously higher in the ER-D5 positive prostatic cancer cases than in ER-D5 negative cases for a certain period of time after the start of treatment. Despite differences in the histo-differentiation degree and clinical stage of prostatic cancer, the ER-D5 positive percentage did not change and remained between 35% and 45%. In cases where another prostatic cancer preparation was taken because of recurrence of prostatic cancer, there were no ER-D5 positive cases at the time of recurrence.(ABSTRACT TRUNCATED AT 250 WORDS)
Activation of TRPV4 channels leads to a consistent tocolytic effect on human myometrial tissues
Background: Human myometrium is a therapeutic target for labor induction and preterm labor.
Objective: This study aimed to assess the physiological role of alternative calcium conductance on contractions triggered by uterotonic drugs in human myometrium. Membrane conductances, supported by TRPV channels, may provide alternative pathways to control either free intracellular and/or submembrane Ca2+-concentration, which in turn will modulate membrane polarization and contractile responses.
Study design: Uterine biopsies were obtained from consenting women undergoing elective caesarean delivery at term without labor (N = 22). Isometric tension measurements were performed on uterine smooth muscle strips (n = 132). Amplitude, frequency, and area under the curve (AUC) of phasic contractions, as well as resting tone, were measured under various experimental conditions. Immuno histo– and cyto-chemistry, as well as Western blot analyses, have been performed with specific antibodies against TRPV1, TRPV3, and TRPV4 proteins. TRPV4 agonists; GSK1016790A, 4αPDD, and 5,6-EET were used to assess the role of TRPV4 channels on rhythmic activity triggered by 30-300 nM oxytocin. 5 μM of ruthenium red was used as an efficient blocker of ionic current through TRPV4 channels. Nanomolar concentrations of iberiotoxin (IbTX) were also used to confirm the downstream involvement of BKCa channels in controlling uterine reactivity and contractility.
Results: The expression of TRPV3 and TRPV4 isoforms has now been demonstrated in human myometrial tissue and cell culture. Nanomolar concentrations of the TRPV4 agonists, (either GSK1016790A or 4αPDD) abolished the rhythmic contractions, resulting in a rapid and consistent tocolytic effect. While 5 μM of ruthenium reversed this tocolytic effect. The addition of IbTX (a BKCa channel blocker) reversed the effects of GSK1016790A. Carvacrol, a TRPV3 agonist, had similar tocolytic effects on rhythmic contractions albeit at higher concentrations. This inhibitory effect was also reversed by ruthenium red.
Conclusion: Collectively, these data suggest that activation of TRPV4 leads to a Ca2+ entry and subsequent BKCa channel activation (increase in open state probability), which in turn hyperpolarizes the myometrial cell membrane, inactivating L-type Ca2+ channels and efficiently abrogates contractile activity. Consequently, alternative Ca2+ conductance supported by TRPV4 plays a physiological role in the modulation of myometrial reactivity.
The real-time polymerase chain reaction.
The scientific, medical, and diagnostic communities have been presented the most powerful tool for quantitative nucleic acids analysis: real-time PCR [Bustin, S.A., 2004. A-Z of Quantitative PCR. IUL Press, San Diego, CA]. This new technique is a refinement of the original Polymerase Chain Reaction (PCR) developed by Kary Mullis and coworkers in the mid 80:ies [Saiki, R.K., et al., 1985. Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia, Science 230, 1350], for which Kary Mullis was awarded the 1993 year’s Nobel prize in Chemistry.
GM-CSF Recombinant Protein |
|||
| 40-281-002mg | ProSci | 0.02 mg | EUR 437.1 |
|
Description: GM-CSF is a hematopoietic growth factor that stimulates the development of neutrophils and macrophages and promotes the proliferation and development of early erythroid megakaryocytic and eosinophilic progenitor cells. It is produced in by endothelial cells, monocytes, fibroblasts and T-lymphocytes. GM-CSF inhibits neutrophil migration and enhances the functional activity of the mature end-cells. The human and murine molecules are species-specific and exhibit no cross-species reactivity. Recombinant human GM-CSF is a 14.6 kDa globular protein consisting of 128 amino acids containing two intramolecular disulfide bonds and two potential N-linked glycosylation sites. |
|||
GM-CSF Recombinant Protein |
|||
| 40-448-0005mg | ProSci | 0.005 mg | EUR 311.1 |
|
Description: GM-CSF is a hematopoietic growth factor that stimulates the development of neutrophils and macrophages and promotes the proliferation and development of early erythroid megakaryocytic and eosinophilic progenitor cells. It is produced in by endothelial cells, monocytes, fibroblasts and T-lymphocytes. GM-CSF inhibits neutrophil migration and enhances the functional activity of the mature end-cells. The human and murine molecules are species-specific and exhibit no cross-species reactivity. Recombinant murine GM-CSF is a 14.2 kDa globular protein consisting of 124 amino acids residues. |
|||
GM-CSF Recombinant Protein |
|||
| 40-448-002mg | ProSci | 0.02 mg | EUR 437.1 |
|
Description: GM-CSF is a hematopoietic growth factor that stimulates the development of neutrophils and macrophages and promotes the proliferation and development of early erythroid megakaryocytic and eosinophilic progenitor cells. It is produced in by endothelial cells, monocytes, fibroblasts and T-lymphocytes. GM-CSF inhibits neutrophil migration and enhances the functional activity of the mature end-cells. The human and murine molecules are species-specific and exhibit no cross-species reactivity. Recombinant murine GM-CSF is a 14.2 kDa globular protein consisting of 124 amino acids residues. |
|||
GM-CSF Recombinant Protein |
|||
| 40-475-0005mg | ProSci | 0.005 mg | EUR 311.1 |
|
Description: GM-CSF is a hematopoietic growth factor that stimulates the development of neutrophils and macrophages and promotes the proliferation and development of early erythroid megakaryocytic and eosinophilic progenitor cells. It is produced in by endothelial cells, monocytes, fibroblasts and T-lymphocytes. GM-CSF inhibits neutrophil migration and enhances the functional activity of the mature end-cells. The human and murine molecules are species-specific and exhibit no cross-species reactivity. Recombinant rat GM-CSF is a 14.5 kDa globular protein consisting of 128 amino acids residues. |
|||
GM-CSF Recombinant Protein |
|||
| 40-475-002mg | ProSci | 0.02 mg | EUR 437.1 |
|
Description: GM-CSF is a hematopoietic growth factor that stimulates the development of neutrophils and macrophages and promotes the proliferation and development of early erythroid megakaryocytic and eosinophilic progenitor cells. It is produced in by endothelial cells, monocytes, fibroblasts and T-lymphocytes. GM-CSF inhibits neutrophil migration and enhances the functional activity of the mature end-cells. The human and murine molecules are species-specific and exhibit no cross-species reactivity. Recombinant rat GM-CSF is a 14.5 kDa globular protein consisting of 128 amino acids residues. |
|||
GM-CSF Recombinant Protein |
|||
| 91-002 | ProSci | 0.05 mg | EUR 714.3 |
|
Description: Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) was initially characterized as a growth factor that can support the in vitro colony formation of granulocyte-macrophage progenitors. It is produced by a number of different cell types (including activated T cells, B cells, macrophages, mast cells, endothelial cells and fibroblasts) in response to cytokine of immune and inflammatory stimuli. Besides granulocyte-macrophage progenitors, GM-CSF is also a growth factor for erythroid, megakaryocyte and eosinophil progenitors. On mature hematopoietic, monocytes/ macrophages and eosinophils. GM-CSF has a functional role on non-hematopoitic cells. It can induce human endothelial cells to migrate and proliferate. Additionally, GM-CSF can also stimulate the proliferation of a number of tumor cell lines, including osteogenic sarcoma, carcinoma and adenocarcinoma cell lines. |
|||
GM-CSF Recombinant Protein |
|||
| 91-030 | ProSci | 0.05 mg | EUR 651.3 |
|
Description: GM-CSF was initially characterized as a growth factor that can support the in vitro colony formation of granulocyte macrophage progenitors. It is produced by a number of different cell types (including activated T cells, B cells, macrophages, mast cells, endothelial cells and fibroblasts) in response to cytokine of immune and inflammatory stimuli. Besides granulocyte-macrophage progenitors, GM-CSF is also a growth factor for erythroid, megakaryocyte and eosinophil progenitors. On mature hematopoietic, monocytes/macrophages, and eosinophils, GM-CSF has also been reported to have a functional role on non-hematopoitic cells. It can induce human endothelial cells to migrate and proliferate. Additionally, GM-CSF can also stimulate the proliferation of a number of tumor cell lines, including osteogenic sarcoma, carcinoma and adenocarcinoma cell lines. |
|||
GM-CSF Recombinant Protein |
|||
| 91-857 | ProSci | 0.05 mg | EUR 619.8 |
|
Description: Granulocyte-macrophage colony-stimulating factor is also known as Colony-stimulating factor,CSF, Molgramostin and Sargramostim. In humans, it is encoded by the CSF2 gene. It belongs to the GM-CSF family. Granulocyte-macrophage colony-stimulating factor is a cytokine that stimulates the growth and differentiation of hematopoietic precursor cells from various lineages, including granulocytes, macrophages, eosinophils and erythrocytes. |
|||
GM-CSF Recombinant Protein |
|||
| 92-446 | ProSci | 0.05 mg | EUR 821.4 |
|
Description: Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) was initially characterized as a growth factorthat can support the in vitro colony formation of granulocyte-macrophage progenitors. It is produced by anumber of different cell types (including activated T cells, B cells, macrophages, mast cells, endothelial cellsand fibroblasts) in response to cytokine of immune and inflammatory stimuli. Besides granulocyte-macrophageprogenitors, GM-CSF is also a growth factor for erythroid, megakaryocyte and eosinophil progenitors. Onmature hematopoietic, monocytes/ macrophages and eosinophils. GM-CSF has a functional role on nonhematopoitic cells. It can induce human endothelial cells to migrate and proliferate. Additionally, GM-CSF canalso stimulate the proliferation of a number of tumor cell lines, including osteogenic sarcoma, carcinoma andadenocarcinoma cell lines. |
|||
GM-CSF Recombinant Protein |
|||
| 92-499 | ProSci | 0.05 mg | EUR 821.4 |
|
Description: Granulocyte-macrophage colony-stimulating factor is an enzyme that in mouse is encoded by the Csf2 gene, belongs to the GM-CSF family.CSF2 is a Cytokine that stimulates the growth and differentiation of hematopoietic precursor cells from various lineages, including granulocytes, macrophages, eosinophils and erythrocytes |
|||
GM-CSF Recombinant Protein |
|||
| 40-593 | ProSci | 0.02 mg | EUR 481.2 |
|
Description: GM-CSF is a hematopoietic growth factor that stimulates the development of neutrophils and macrophages and promotes the proliferation and development of early erythroid megakaryocytic and eosinophilic progenitor cells. It is produced in endothelial cells, monocytes, fibroblasts and T-lymphocytes. GM-CSF inhibits neutrophil migration and enhances the functional activity of the mature end-cells. The human and murine molecules are species-specific and exhibit no cross-species reactivity. Recombinant human GM-CSF is a 14.6 kDa globular protein consisting of 128 amino acids containing two intramolecular disulfide bonds and two potential N-linked glycosylation sites. |
|||
GM-CSF Recombinant Protein |
|||
| 40-617 | ProSci | 0.02 mg | EUR 481.2 |
|
Description: GM-CSF is a hematopoietic growth factor that stimulates the development of neutrophils and macrophages and promotes the proliferation and development of early erythroid megakaryocytic and eosinophilic progenitor cells. It is produced in endothelial cells, monocytes, fibroblasts and T-lymphocytes. GM-CSF inhibits neutrophil migration and enhances the functional activity of the mature end-cells. The human and murine molecules are species-specific and exhibit no cross-species reactivity. Recombinant murine GM-CSF is a 14.2 kDa globular protein consisting of 124 amino acids residues. . |
|||
GM-CSF Recombinant Protein |
|||
| 40-621 | ProSci | 0.02 mg | EUR 481.2 |
|
Description: GM-CSF is a hematopoietic growth factor that stimulates the development of neutrophils and macrophages and promotes the proliferation and development of early erythroid megakaryocytic and eosinophilic progenitor cells. It is produced in by endothelial cells, monocytes, fibroblasts and T-lymphocytes. GM-CSF inhibits neutrophil migration and enhances the functional activity of the mature end-cells. The human and murine molecules are species-specific and exhibit no cross-species reactivity. Recombinant murine GM-CSF is a 14.5 kDa globular protein consisting of 128 amino acids residues. |
|||
GM CSF Recombinant Protein |
|||
| 96-356 | ProSci | 0.02 mg | EUR 500.1 |
|
Description: Granulocyte-macrophage colony-stimulating factor (GM-CSF) is also known as Colony stimulating factor 2 (granulocyte-macrophage), is a cytokine initially characterized by its ability to induce colonies of granulocytes and macrophages from myeloid progenitor cells, and is secreted by macrophages, T cells, mast cells, endothelial cells and fibroblasts. GM-CSF is a cytokine that functions as a white blood cell growth factor. GM-CSF stimulates stem cells to produce granulocytes (neutrophils, eosinophils, and basophils) and monocytes. Monocytes exitthe circulation and migrate into tissue, whereupon they mature into macrophages and dendritic cells. Thus, it is part of the immune/inflammatory cascade, by which activation of a small number of macrophages can rapidly lead to an increase in their numbers, a process crucial for fighting infection. The active form of the protein is found extracellularly as a homodimer. Human GM-CSF glycosylated in its mature form. As a part of the immune/inflammatory cascade, GM-CSF promotes Th1 biased immune response, angiogenesis, allergic inflammation, and the development of autoimmunity, and thus worthy of consideration for therapeutic target. GM-CSF has also recently been evaluated in clinical trials for its potential as a vaccine adjuvant in HIV-infected patients. The preliminary results have been promising. GM-CSF is also used as a medication to stimulate the production of white blood cells following chemotherapy. |
|||
GM-CSF Recombinant Protein |
|||
| 90-553 | ProSci | 50 ug | EUR 588.3 |
|
Description: Human GM-CSF is a 24 kDa glycoprotein produced by a variety of cell types, including T and B lymphocytes, macrophages, keratinocytes, eosinophils, neutrophils, and endothelial cells in response to cytokine or inflammatory stimuli. GM-CSF was initially identified on the basis of its capacity to stimulate the clonal proliferation of myeloid precursors in vitro. GM-CSF promotes a Th1 biased immune response, allergic inflammation, and the development of autoimmunity. GM-CSF are particularly effective as antitumor vaccines. GM-CSF regulates multiple biological activities through activation of the GM-CSF receptor (GMCSFR), a member of the type I cytokine receptor group comprising alpha and beta subunits. |
|||
GM-CSF, Porcine Recombinant |
|||
| P1561-10 | Biovision | 10 µg | EUR 187.2 |
GM-CSF, Porcine Recombinant |
|||
| P1561-50 | Biovision | 50 µg | EUR 661.2 |
GM-CSF, human recombinant |
|||
| P1012-.01 | ApexBio | 10 µg | EUR 375.6 |
|
Description: Granulocyte Macrophage Colony stimulating Factor (GM-CSF) is a cytokine that stimulates the colony formation of granulocyte-macrophage progenitors. GM-CSF is a pleiotropic cytokine and a member of endogenous cytokine family of the hematopoietic system |
|||
GM-CSF, human recombinant |
|||
| P1012-.1 | ApexBio | 100 µg | EUR 1220.4 |
|
Description: Granulocyte Macrophage Colony stimulating Factor (GM-CSF) is a cytokine that stimulates the colony formation of granulocyte-macrophage progenitors. GM-CSF is a pleiotropic cytokine and a member of endogenous cytokine family of the hematopoietic system |
|||
GM-CSF, human recombinant |
|||
| P1012-1 | ApexBio | 1 mg | EUR 5071.2 |
|
Description: Granulocyte Macrophage Colony stimulating Factor (GM-CSF) is a cytokine that stimulates the colony formation of granulocyte-macrophage progenitors. GM-CSF is a pleiotropic cytokine and a member of endogenous cytokine family of the hematopoietic system |
|||
GM-CSF, murine recombinant |
|||
| P1013-.01 | ApexBio | 10 µg | EUR 375.6 |
|
Description: Granulocyte Macrophage Colony stimulating Factor (GM-CSF) is a cytokine that stimulates the colony formation of granulocyte-macrophage progenitors. GM-CSF is a pleiotropic cytokine and a member of endogenous cytokine family of the hematopoietic system. |
|||
GM-CSF, murine recombinant |
|||
| P1013-.1 | ApexBio | 100 µg | EUR 1220.4 |
|
Description: Granulocyte Macrophage Colony stimulating Factor (GM-CSF) is a cytokine that stimulates the colony formation of granulocyte-macrophage progenitors. GM-CSF is a pleiotropic cytokine and a member of endogenous cytokine family of the hematopoietic system. |
|||
GM-CSF, murine recombinant |
|||
| P1013-1 | ApexBio | 1 mg | EUR 5071.2 |
|
Description: Granulocyte Macrophage Colony stimulating Factor (GM-CSF) is a cytokine that stimulates the colony formation of granulocyte-macrophage progenitors. GM-CSF is a pleiotropic cytokine and a member of endogenous cytokine family of the hematopoietic system. |
|||
GM-CSF, rat recombinant |
|||
| P1014-.1 | ApexBio | 100 µg | EUR 1220.4 |
|
Description: Granulocyte Macrophage Colony stimulating Factor (GM-CSF) is a cytokine that stimulates the colony formation of granulocyte-macrophage progenitors. GM-CSF is a pleiotropic cytokine and a member of endogenous cytokine family of the hematopoietic system. |
|||
GM-CSF, rat recombinant |
|||
| P1014-1 | ApexBio | 1 mg | EUR 5822.4 |
|
Description: Granulocyte Macrophage Colony stimulating Factor (GM-CSF) is a cytokine that stimulates the colony formation of granulocyte-macrophage progenitors. GM-CSF is a pleiotropic cytokine and a member of endogenous cytokine family of the hematopoietic system. |
|||
Recombinant Human GM-CSF |
|||
| SJA01-03 | Cusabio | 10µg/vial | EUR 342 |
Recombinant Human GM-CSF |
|||
| SJA01-04 | Amyotop | 50µg/vial | EUR 846 |
Recombinant Mouse GM-CSF |
|||
| SJF05-01 | Amyotop | 10µg/vial | EUR 307.2 |
Recombinant Mouse GM-CSF |
|||
| SJF05-02 | Amyotop | 50µg/vial | EUR 690 |
GM-CSF, human recombinant |
|||
| 4100-10 | Biovision | each | EUR 307.2 |
GM-CSF, human recombinant |
|||
| 4100-100 | Biovision | each | EUR 874.8 |
GM-CSF, human recombinant |
|||
| 4100-1000 | Biovision | each | EUR 3974.4 |
GM-CSF, murine recombinant |
|||
| 4101-10 | Biovision | each | EUR 307.2 |
GM-CSF, murine recombinant |
|||
| 4101-100 | Biovision | each | EUR 874.8 |
GM-CSF, murine recombinant |
|||
| 4101-1000 | Biovision | each | EUR 3974.4 |
GM-CSF, rat recombinant |
|||
| 4102-10 | Biovision | each | EUR 307.2 |
GM-CSF, rat recombinant |
|||
| 4102-100 | Biovision | each | EUR 966 |
GM-CSF, rat recombinant |
|||
| 4102-1000 | Biovision | each | EUR 4561.2 |
Filgrastim (rHuG-CSF) |
|||
| rHuG-CSF | Amyotop | 300µg/vial | EUR 270 |
Molgramostim (rHuGM-CSF) |
|||
| rHuGM-CSF | Amyotop | 300µg/vial | EUR 298.8 |
rHu GM-CSF |
|||
| AK9707-0005 | Akron Biotech | 5µg | Ask for price |
rHu GM-CSF |
|||
| AK9707-0020 | Akron Biotech | 20µg | Ask for price |
rHu GM-CSF |
|||
| AK9707-0100 | Akron Biotech | 100µg | Ask for price |
rHu GM-CSF |
|||
| AK9707-1000 | Akron Biotech | 1mg | Ask for price |
His-GM-CSF |
|||
| E13-010-1 | EnoGene | 10μg | EUR 349.2 |
His-GM-CSF |
|||
| E13-010-2 | EnoGene | 50μg | EUR 840 |
GM-CSF antibody |
|||
| 70R-GR026 | Fitzgerald | 50 ug | EUR 327.6 |
|
Description: Affinity purified Rabbit polyclonal GM-CSF antibody |
|||
GM-CSF antibody |
|||
| 70-GR30 | Fitzgerald | 50 ug | EUR 357.6 |
|
Description: Affinity purified Rabbit polyclonal GM-CSF antibody |
|||
GM-CSF protein |
|||
| 30R-AG014 | Fitzgerald | 5 ug | EUR 159.6 |
|
Description: Purified recombinant Human GM-CSF protein |
|||
GM-CSF protein |
|||
| 30R-AG016 | Fitzgerald | 50 ug | EUR 634.8 |
|
Description: Purified recombinant Human GM-CSF protein |
|||
GM-CSF protein |
|||
| 30R-AG022 | Fitzgerald | 20 ug | EUR 327.6 |
|
Description: Purified recombinant Human GM-CSF protein |
|||
GM-CSF, Human |
|||
| LF-P0278 | Abfrontier | 10 ug | EUR 324 |
|
Description: GM-CSF, Human protein |
|||
GM-CSF, Human |
|||
| LF-P0278A | Abfrontier | 100 ug | EUR 2173.2 |
|
Description: GM-CSF, Human protein |
|||
GM-CSF/CSF2 |
|||
| E21-C79 | EnoGene | 10ug | EUR 411.6 |
GM-CSF, Human |
|||
| HY-P7016A | MedChemExpress | 50ug | EUR 529.2 |
GM-CSF, Mouse |
|||
| HY-P7361 | MedChemExpress | 50ug | EUR 596.4 |
GM - CSF Human |
|||
| PR27068 | Neuromics | 2 ug | EUR 229.2 |
GM - CSF Rat |
|||
| PR27071 | Neuromics | 2 ug | EUR 177.6 |
GM - CSF Sf9 |
|||
| PR27072 | Neuromics | 2 ug | EUR 177.6 |
GM - CSF Mouse |
|||
| PR27074 | Neuromics | 2 ug | EUR 229.2 |
anti-GM-CSF |
|||
| YF-PA11125 | Abfrontier | 100 ug | EUR 483.6 |
|
Description: Rabbit polyclonal to GM-CSF |
|||
GM-CSF Antibody |
|||
| R30528 | NSJ Bioreagents | 100 ug | EUR 419 |
GM-CSF Antibody |
|||
| 5100-100 | Biovision | each | EUR 379.2 |
GM-CSF Antibody |
|||
| 5100-30T | Biovision | each | EUR 175.2 |
GM-CSF Antibody |
|||
| 5101-100 | Biovision | each | EUR 379.2 |
GM-CSF Antibody |
|||
| 5101-30T | Biovision | each | EUR 175.2 |
Nori® Bovine GM-CSF ELISA Kit |
|||
| GR112275 | Genorise Scientific | 96-well | EUR 553.2 |
Recombinant Mouse GM-CSF/CSF2 |
|||
| CK02-10ug | Novoprotein | 10ug | EUR 242.4 |
|
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB,150mM NaCl, pH7.4. |
|||
Recombinant Mouse GM-CSF/CSF2 |
|||
| CK02-1mg | Novoprotein | 1mg | EUR 2983.2 |
|
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB,150mM NaCl, pH7.4. |
|||
Recombinant Mouse GM-CSF/CSF2 |
|||
| CK02-500ug | Novoprotein | 500ug | EUR 1935.6 |
|
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB,150mM NaCl, pH7.4. |
|||
Recombinant Mouse GM-CSF/CSF2 |
|||
| CK02-50ug | Novoprotein | 50ug | EUR 595.2 |
|
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB,150mM NaCl, pH7.4. |
|||
Recombinant Rat GM-CSF Protein |
|||
| PROTP48750-1 | BosterBio | 20ug | EUR 380.4 |
|
Description: GM-CSF is a hematopoietic growth factor that stimulates the development of neutrophils and macrophages and promotes the proliferation and development of early erythroid megakaryocytic and eosinophilic progenitor cells. It is produced in by endothelial cells, monocytes, fibroblasts and T-lymphocytes. GM-CSF inhibits neutrophil migration and enhances the functional activity of the mature end-cells. The human and murine molecules are species-specific and exhibit no cross-species reactivity. Recombinant rat GM-CSF is a 14.5 kDa globular protein consisting of 128 amino acids residues. |
|||
Recombinant Murine GM-CSF Protein |
|||
| PROTP01587-1 | BosterBio | 20ug | EUR 380.4 |
|
Description: GM-CSF is a hematopoietic growth factor that stimulates the development of neutrophils and macrophages and promotes the proliferation and development of early erythroid megakaryocytic and eosinophilic progenitor cells. It is produced in endothelial cells, monocytes, fibroblasts and T-lymphocytes. GM-CSF inhibits neutrophil migration and enhances the functional activity of the mature end-cells. The human and murine molecules are species-specific and exhibit no cross-species reactivity. Recombinant murine GM-CSF is a 14.2 kDa globular protein consisting of 125 amino acid residues. |
|||
Recombinant Human GM-CSF Protein |
|||
| PROTP04141-6 | BosterBio | 20ug | EUR 380.4 |
|
Description: GM-CSF is a hematopoietic growth factor that stimulates the development of neutrophils and macrophages and promotes the proliferation and development of early erythroid megakaryocytic and eosinophilic progenitor cells. It is produced in endothelial cells, monocytes, fibroblasts and T-lymphocytes. GM-CSF inhibits neutrophil migration and enhances the functional activity of the mature end-cells. The human and murine molecules are species-specific and exhibit no cross-species reactivity. Recombinant human GM-CSF is a 14.6 kDa globular protein consisting of 128 amino acids containing two intramolecular disulfide bonds and two potential N-linked glycosylation sites. |
|||
Canine GM-CSF Recombinant Protein |
|||
| R00911-1 | BosterBio | 5ug/vial | EUR 310.8 |
|
Description: Granulocyte-macrophage colony-stimulating factor (GM-CSF) is a protein secreted by macrophages, T cells, mast cells, NK cells, endothelial cells and fibroblasts. GM-CSF stimulates stem cells to produce granulocytes (neutrophils, eosinophils, and basophils) and monocytes. Canine GM-CSF Recombinant Protein is purified GM-CSF produced in yeast. |
|||
Chicken GM-CSF Recombinant Protein |
|||
| R00911-2 | BosterBio | 5ug/vial | EUR 310.8 |
|
Description: Granulocyte-macrophage colony-stimulating factor (GM-CSF) is a protein secreted by macrophages, T cells, mast cells, NK cells, endothelial cells and fibroblasts. GM-CSF stimulates stem cells to produce granulocytes (neutrophils, eosinophils, and basophils) and monocytes. Chicken GM-CSF Recombinant Protein is purified GM-CSF produced in yeast. |
|||
Equine GM-CSF Recombinant Protein |
|||
| R00911-3 | BosterBio | 5ug/vial | EUR 310.8 |
|
Description: Granulocyte-macrophage colony-stimulating factor (GM-CSF) is a protein secreted by macrophages, T cells, mast cells, NK cells, endothelial cells and fibroblasts. GM-CSF stimulates stem cells to produce granulocytes (neutrophils, eosinophils, and basophils) and monocytes. Equine GM-CSF Recombinant Protein is purified GM-CSF produced in yeast |
|||
Human GM-CSF Recombinant Protein |
|||
| R00911-4 | BosterBio | 5ug/vial | EUR 310.8 |
|
Description: Granulocyte-macrophage colony-stimulating factor (GM-CSF) is a protein secreted by macrophages, T cells, mast cells, NK cells, endothelial cells and fibroblasts. GM-CSF stimulates stem cells to produce granulocytes (neutrophils, eosinophils, and basophils) and monocytes. Human GM-CSF Recombinant Protein is purified GM-CSF produced in yeast. |
|||
Mouse GM-CSF Recombinant Protein |
|||
| R00911-5 | BosterBio | 5ug/vial | EUR 310.8 |
|
Description: Granulocyte-macrophage colony-stimulating factor (GM-CSF) is a protein secreted by macrophages, T cells, mast cells, NK cells, endothelial cells and fibroblasts. GM-CSF stimulates stem cells to produce granulocytes (neutrophils, eosinophils, and basophils) and monocytes. Mouse GM-CSF Recombinant Protein is purified GM-CSF produced in yeast. |
|||
Rabbit GM-CSF Recombinant Protein |
|||
| R00911-6 | BosterBio | 5ug/vial | EUR 310.8 |
|
Description: Granulocyte-macrophage colony-stimulating factor (GM-CSF) is a protein secreted by macrophages, T cells, mast cells, NK cells, endothelial cells and fibroblasts. GM-CSF stimulates stem cells to produce granulocytes and monocytes and is glycosylated in its mature form. |
|||
Swine GM-CSF Recombinant Protein |
|||
| R00911-7 | BosterBio | 5ug/vial | EUR 310.8 |
|
Description: Granulocyte-macrophage colony-stimulating factor (GM-CSF) is a protein secreted by macrophages, T cells, mast cells, NK cells, endothelial cells and fibroblasts. GM-CSF stimulates stem cells to produce granulocytes (neutrophils, eosinophils, and basophils) and monocytes. Swine GM-CSF Recombinant Protein is purified GM-CSF produced in yeast. |
|||
Anti-Cat IgM Antibody | GM-20A |
|||
| GM-20A | Immunology Consultants Laboratory | 1.0 mg | EUR 221 |
|
Description: Anti-Cat IgM Antibody | GM-20A | Immunology Consultants Laboratory Host: Goat Format: Unconjugated AP Product Type: Secondary Antibody Antibody Clonality: Polyclonal |
|||
Anti-Rat IgM Antibody | GM-25A |
|||
| GM-25A | Immunology Consultants Laboratory | 1.0 mg | EUR 251 |
|
Description: Anti-Rat IgM Antibody | GM-25A | Immunology Consultants Laboratory Host: Goat Format: Unconjugated AP Product Type: Secondary Antibody Antibody Clonality: Polyclonal |
|||
Anti-Dog IgM Antibody | GM-40A |
|||
| GM-40A | Immunology Consultants Laboratory | 1.0 mg | EUR 221 |
|
Description: Anti-Dog IgM Antibody | GM-40A | Immunology Consultants Laboratory Host: Goat Format: Unconjugated AP Product Type: Secondary Antibody Antibody Clonality: Polyclonal |
|||
Anti-Dog IgM Antibody | GM-40P |
|||
| GM-40P | Immunology Consultants Laboratory | 1.0 mg | EUR 289 |
|
Description: Anti-Dog IgM Antibody | GM-40P | Immunology Consultants Laboratory Host: Goat Format: HRP Conjugated Product Type: Secondary Antibody Antibody Clonality: Polyclonal |
|||
Anti-Human IgM Antibody | GM-80A |
|||
| GM-80A | Immunology Consultants Laboratory | 1.0 mg | EUR 175 |
|
Description: Anti-Human IgM Antibody | GM-80A | Immunology Consultants Laboratory Host: Goat Format: Unconjugated AP Product Type: Secondary Antibody Antibody Clonality: Polyclonal |
|||
Anti-Human IgM Antibody | GM-80AD |
|||
| GM-80AD | Immunology Consultants Laboratory | 1.0 mg | EUR 296 |
|
Description: Anti-Human IgM Antibody | GM-80AD | Immunology Consultants Laboratory Host: Goat Format: F(ab')2 Product Type: Secondary Antibody Antibody Clonality: Polyclonal |
|||
Anti-Human IgM Antibody | GM-80P |
|||
| GM-80P | Immunology Consultants Laboratory | 1.0 mg | EUR 243 |
|
Description: Anti-Human IgM Antibody | GM-80P | Immunology Consultants Laboratory Host: Goat Format: HRP Conjugated Product Type: Secondary Antibody Antibody Clonality: Polyclonal |
|||
Anti-Mouse IgM Antibody | GM-90A |
|||
| GM-90A | Immunology Consultants Laboratory | 1.0 mg | EUR 206 |
|
Description: Anti-Mouse IgM Antibody | GM-90A | Immunology Consultants Laboratory Host: Goat Format: Unconjugated AP Product Type: Secondary Antibody Antibody Clonality: Polyclonal |
|||
Bovine Granulocyte macrophage colony stimulating factor, GM- CSF |
|||
| ELA-E0045b | Lifescience Market | 96 Tests | EUR 1113.6 |
anti- GM-CSF antibody |
|||
| FNab03520 | FN Test | 100µg | EUR 658.5 |
|
Description: Antibody raised against GM-CSF |
|||
GM-CSF Polyclonal Antibody |
|||
| ES8638-100ul | ELK Biotech | 100ul | EUR 334.8 |
|
Description: A Rabbit Polyclonal antibody against GM-CSF from Human. This antibody is tested and validated for IHC, WB, ELISA |
|||
GM-CSF Polyclonal Antibody |
|||
| ES8638-50ul | ELK Biotech | 50ul | EUR 248.4 |
|
Description: A Rabbit Polyclonal antibody against GM-CSF from Human. This antibody is tested and validated for IHC, WB, ELISA |
|||
GM-CSF Polyclonal Antibody |
|||
| 46884-100ul | SAB | 100ul | EUR 302.4 |
GM-CSF Polyclonal Antibody |
|||
| 46884-50ul | SAB | 50ul | EUR 224.4 |
GM-CSF (17-31) |
|||
| 5-01233 | CHI Scientific | 4 x 1mg | Ask for price |
GM-CSF (96-112) |
|||
| 5-01234 | CHI Scientific | 4 x 1mg | Ask for price |
GM-CSF antibody (biotin) |
|||
| 60R-GR003bt | Fitzgerald | 25 ug | EUR 327.6 |
|
Description: Rabbit polyclonal GM-CSF antibody (biotin) conjugated |
|||
Mouse GM-CSF protein |
|||
| 30R-1134 | Fitzgerald | 100 ug | EUR 418.8 |
|
Description: Purified recombinant Mouse GM-CSF protein |
|||
Mouse GM-CSF Antibody |
|||
| 32865-05111 | AssayPro | 150 ug | EUR 313.2 |
Human GM-CSF Antibody |
|||
| 32934-05111 | AssayPro | 150 ug | EUR 313.2 |
GM-CSF Polyclonal Antibody |
|||
| ABP58647-003ml | Abbkine | 0.03ml | EUR 189.6 |
|
Description: A polyclonal antibody for detection of GM-CSF from Human. This GM-CSF antibody is for IHC-P, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human GM-CSF protein at amino acid sequence of 100-144 |
|||
GM-CSF Polyclonal Antibody |
|||
| ABP58647-01ml | Abbkine | 0.1ml | EUR 346.8 |
|
Description: A polyclonal antibody for detection of GM-CSF from Human. This GM-CSF antibody is for IHC-P, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human GM-CSF protein at amino acid sequence of 100-144 |
|||
GM-CSF Polyclonal Antibody |
|||
| ABP58647-02ml | Abbkine | 0.2ml | EUR 496.8 |
|
Description: A polyclonal antibody for detection of GM-CSF from Human. This GM-CSF antibody is for IHC-P, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human GM-CSF protein at amino acid sequence of 100-144 |
|||
Human GM-CSF Protein |
|||
| abx060156-100ug | Abbexa | 100 ug | EUR 693.6 |
Human GM-CSF Protein |
|||
| abx060239-100ug | Abbexa | 100 ug | EUR 693.6 |
Human GM-CSF Protein |
|||
| abx060789-20ug | Abbexa | 20 ug | EUR 543.6 |
GM-CSF Blocking Peptide |
|||
| 20-abx064143 | Abbexa |
|
|
Polyclonal GM-CSF Antibody |
|||
| APR00257G | Leading Biology | 0.1mg | EUR 580.8 |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human GM-CSF . This antibody is tested and proven to work in the following applications: |
|||
Polyclonal GM-CSF Antibody |
|||
| APR00258G | Leading Biology | 0.1mg | EUR 580.8 |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human GM-CSF . This antibody is tested and proven to work in the following applications: |
|||
Polyclonal GM-CSF Antibody |
|||
| APR00259G | Leading Biology | 0.05mg | EUR 580.8 |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human GM-CSF . This antibody is tested and proven to work in the following applications: |
|||
GM-CSF, Rhesus Macaque |
|||
| HY-P7184 | MedChemExpress | 10ug | EUR 280.8 |
rec GM-CSF (murine) |
|||
| H-7380.0005 | Bachem | 5.0µg | EUR 316.8 |
rec GM-CSF (murine) |
|||
| H-7380.0010 | Bachem | 10.0µg | EUR 457.2 |
rec GM-CSF (murine) |
|||
| H-7380.0020 | Bachem | 20.0µg | EUR 868.8 |